TY - JOUR T1 - Newborn Differential DNA Methylation and Subcortical Brain Volumes as Early Signs of Severe Delay in Neurodevelopment JF - medRxiv DO - 10.1101/2020.03.13.20035501 SP - 2020.03.13.20035501 AU - Anke Hüls AU - Catherine J Wedderburn AU - Nynke A Groenewold AU - Nicole Gladish AU - Meaghan Jones AU - Nastassja Koen AU - Julia L MacIsaac AU - David TS Lin AU - Katia E Ramadori AU - Michael P Epstein AU - Kirsten A. Donald AU - Michael S Kobor AU - Heather J Zar AU - Dan J Stein Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/03/17/2020.03.13.20035501.abstract N2 - Objective The first two years of life are a critical period of rapid brain development. Since early neurodevelopment is influenced by prenatal risk factors and genetics, neonatal biomarkers can potentially provide the opportunity to detect early signs of neurodevelopmental delay. We analyzed associations between DNA methylation levels from cord blood, neonatal MRI imaging data, and neurodevelopmental delay at two years of age.Methods Neurodevelopment was assessed in 161 children from the South African Drakenstein Child Health Study at two years of age using the Bayley Scales of Infant and Toddler Development. We performed an epigenome-wide association study of neurodevelopmental delay using DNA methylation levels from cord blood. A mediation analysis was conducted to analyze if associations between differential methylation and neurodevelopmental delay were mediated by changes in neonatal brain volumes.Results We found epigenome-wide significant associations between severe neurodevelopmental delay and differential methylation in the SPTBN4 locus (cg26971411, p-value=3.10×10−08), an intergenic region on chromosome 11 (cg00490349, p-value=2.41×10−08) and in the NBPF8 locus (FDR p-value for the region=9.06×10−05). While these associations were not mediated by neonatal brain volume, neonatal caudate volumes were independently associated with severe neurodevelopmental delay, particularly with language development (p-value=0.0443) and delay in motor function (p-value=0.0082).Conclusion Differential methylation levels from cord blood and increased neonatal caudate volumes were associated with severe neurodevelopmental delay at two years of age. If confirmed by future studies, our findings could have implications for early detection of developmental delay and timely implementation of interventions, which are essential for positive child development.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe Drakenstein Child Health Study was funded by the Bill & Melinda Gates Foundation (OPP 1017641), Discovery Foundation, Medical Research Council South Africa, National Research Foundation South Africa, CIDRI Clinical Fellowship and Wellcome Trust (204755/2/16/z). AH was supported by a research fellowship from the Deutsche Forschungsgemeinschaft (DFG; HU 2731/1-1) and by the HERCULES Center (NIEHS P30ES019776). MPE was supported by NIH grant R01 GM117946. NAG was supported by a Claude Leon Fellowship. DJS, HJZ, KAD and NK are supported by the SA Medical Research Council (SAMRC). PDS is supported by the National Health and Medical Research Council, Australia. CJW is supported by the Wellcome Trust through a Research Training Fellowship [203525/Z/16/Z]. Support for the neuroimaging was also received by KAD from an ABMRF young investigator grant, the South African Medical Association and the Harry Crossley Foundation. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of manuscript.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData are available upon request from the Steering Committee (Prof. Heather Zar, heather.zar{at}uct.ac.za) ER -